Chun-Pyn Shen Dds

Chun-Pyn Shen, DDS PhD, possesses extensive experience in regulatory affairs and project management within the biotechnology and pharmaceutical industries. Currently serving as Vice President and Head of Regulatory Affairs and Global Project Lead at IMPACT Therapeutics, Chun-Pyn has held significant roles at Dynamicure Biotechnology, Hengenix Biotech, Inc., EMD Serono, Inc., and Mallinckrodt Pharmaceuticals. Educationally, Chun-Pyn Shen completed a Ph.D. in Molecular Biology and Genetics at the University of Pennsylvania and a post-doctoral fellowship in drosophila genetics at the University of California, San Francisco.